AQXP stock news

The Shareholder Yield of Aquinox Pharmaceuticals, Inc. (NasdaqGM:AQXP) is -0.003068. The Shareholder Yield is a tool used by investors to see how much money shareholders are receiving from a firm thro Read more
Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) is a company in the Drugs – Generic industry and that’s how we compare it to its peers. The contrasting will be based on the institutional ownership, ear Read more
Investors may be tracking technical signals on shares of Aquinox Pharmaceutic (AQXP). After a recent check, we have spotted the short-term moving average Hilo channel at Hold. This indicator calculate Read more
Individual investors might be digging a little deeper into the playbook in order to create a winning plan for the remainder of the calendar year. The diligent investor typically has a portfolio that i Read more
Icon Advisers Inc increased Chevron Corporation (CVX) stake by 61.32% reported in 2018Q4 SEC filing. Icon Advisers Inc acquired 85,300 shares as Chevron Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) had a Read more
Stock analysis typically falls under the two main categories of fundamental and technical. Fundamental analysis involves diving into company financials. Fundamental analysts study how the company is p Read more
Investors may be taking a look at the longer term performance on shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP). After a recent check, we have noted that the stock has lost -81.99% in the previ Read more
Investors have placed Aquinox Pharmaceutic (AQXP) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is strong upward momentum building for the shares. If Aroon-Up cro Read more
Traders may be focused on various technical signals on shares of Aquinox Pharmaceutic (AQXP). Today we have focused on the 50-day MA vs Price signal. During a recent scan, we have seen that the curren Read more

Aquinox Pharmaceutic (AQXP): MACD in Focus

03:09am, Monday, 25'th Mar 2019
Moving average convergence divergence (MACD) is a trend-following momentum indicator that illustrates the relationship between two moving averages. MACD is calculated by subtracting the 26-day exponen Read more
Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) is anticipated to report earnings of 66.20% per share for next year, according to analysts. Analysts are expecting an EPS change of 40.00% for the current y Read more
Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has received a consensus recommendation of “Hold” from the seven analysts that are covering the firm, MarketBeat reports. Five research analysts have rate Read more
Analysts expect Iron Mountain Incorporated (NYSE:IRM) to report $0.52 EPS on April, 25.They anticipate $0.03 EPS change or 6.12% from last quarter’s $0.49 EPS. IRM’s profit would be $148.91 millio Read more
Investors may be focusing on technical signals for Aquinox Pharmaceutic (AQXP). Looking at the reading from the 20-day moving average vs price signal, we can see that the signal is showing Buy. This i Read more
Focusing in on technical signals for Aquinox Pharmaceutic (AQXP), we have noted that the short-term moving average Hilo channel is currently Hold. This indicator calculates the moving average based on Read more

Proudly made at